NEPHRO CARE INDIA LIMITED Share Price

₹ 80.80

+₹3.20 (4.12%)
1D
Last updated 09 Nov, 2026, 15:29 IST
NSE: NEPHROCARE
|
Healthcare Services

NEPHRO CARE INDIA LIMITED Share Price Today

As of 11 Nov 2026, NEPHRO CARE INDIA LIMITED share price is ₹80.80. The stock opened at ₹80.05, compared to its previous close of ₹77.60. During today's trading session, NEPHRO CARE INDIA LIMITED share price moved in the range of ₹78.35 to ₹81.00, with an average price of ₹79.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹50.05 and a high of ₹156.35. On the performance front, NEPHRO CARE INDIA LIMITED share price has declined by 7.36% over the last six months and is down 37.54% on a year-on-year basis.

Share price over the last 1 day rose from 78.65 to 80.80, ranging between 78.35 and 81.00.
₹78.35
4.12% up today
₹81.00
1D LOW
1D HIGH

NEPHRO CARE INDIA LIMITED Stock Insights

Latest Earning
Op Profit TrendUp by 100.77% QoQ
Latest Earning
Net Profit TrendUp by 61.00% QoQ
Latest Earning
Revenue TrendUp by 6.64% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 37.05 % in last 1 yr
Shareholding Pattern
DIIDII decreased stake by 33.77%
Shareholding Pattern
FIIFII decreased stake by 24.50%
NEPHRO CARE INDIA LIMITED stock performance
Open₹80.05
High₹81.00
Low₹78.35
Prev. close₹77.60
NEPHRO CARE INDIA LIMITED trading activity
Volume5,600
Average traded price₹79.98
Last traded time03:29:19 09 Nov
Last traded quantity400
Circuit
L
H
₹64.00
₹95.90
52-week
L
H
₹50.05
₹156.35
Mkt Cap Cr
131.81
P/E
25.37
P/B
1.5
ROA
5.88%
ROE
5.93%
ROCE
8.38%
Quick Ratio
1.87
EV/EBITDA
7.99

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Nephro Care has not beaten FD return of 7%
Valuation: 3 out of 5, Fairly Valued
Valuation
Fairly Valued
Nephro Care appears to be fairly valued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Nephro Care earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,22,763.3452.5211.589.65%21.14%18.94%0.9828.72
Max Healthcare90,027.8964.537.867.37%12.18%13.24%0.8436.17
Manipal Health Enterprises Limited87,426.5596.475.324.07%10.59%9.51%1.1734.17
Aster DM Healthcare65,458.24113.388.592.07%8.48%10.1%1.976.35
Fortis Healthcare58,358.2654.945.576.47%9.91%12.56%0.827.75
Narayana Hrudayalaya39,293.4745.07.736.43%17.17%12.26%2.0721.96
Global Health37,591.7762.68.889.28%14.3%16.02%2.5431.65
Dr. Lal Path Labs33,836.6457.5512.3317.01%21.32%26.75%3.3833.6
KRISHNA INST OF MED SCI L30,866.28154.087.722.21%5.4%7.29%0.6836.33
Syngene International17,638.3294.783.632.79%5.47%7.06%1.2924.08

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NEPHRO CARE INDIA LIMITED Company Background

ISIN
INE0SUN01013
Sector Market Cap
₹ 131.81 Cr

Nephro Care India Limited is an India-based company that operates as a healthcare provider. Its business is to provide a comprehensive 360-degree healthcare service to patients with kidney-related services. It operates only in non-invasive service. It offers a range of clinical and lifestyle solutions and services and renal insufficiency treatment for patients. Its treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. It provides holistic care for renal failure patients, which includes consultation, treatment, and yoga. It offers nutritional support for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, Lupus nephropathy, and ADPKD. It operates various clinics, such as Renal Transplant, Urology, and Vascular Surgery. It also offers other services, such as Pulmonary function test, EMG/NCV-testing, Uroflowmetry, EEG, Polysomnography, and others.

NEPHRO CARE INDIA LIMITED Financial Highlights

  • Revenue: NEPHRO CARE INDIA LIMITED reported revenue of ₹90.28 crore in FY26 vs ₹47.56 crore in FY25. It showed an increase of 89.82% on a yearly basis.
  • Operating Profit: NEPHRO CARE INDIA LIMITED reported an operating profit of ₹4.64 crore in FY26 vs ₹4.83 crore in FY25. It showed a decrease of 3.93% on a year-on-year basis.
  • Net Profit: NEPHRO CARE INDIA LIMITED reported a net profit of ₹3.37 crore in FY26 vs ₹3.64 crore in FY25. It showed a decrease of 7.42% on a yearly basis.

NEPHRO CARE INDIA LIMITED Quarterly Result Highlights

  • NEPHRO CARE INDIA LIMITED reported revenue of ₹29.41 crore in Jun 2026, compared with ₹27.58 crore in Mar 2026, representing an increase of 6.64% on a quarter-on-quarter (QoQ) basis.
  • NEPHRO CARE INDIA LIMITED reported an operating profit of ₹2.61 crore in Jun 2026, compared with ₹1.30 crore in Mar 2026, representing an increase of 100.77% on a quarter-on-quarter (QoQ) basis.
  • NEPHRO CARE INDIA LIMITED reported a profit of ₹1.61 crore in Jun 2026, compared with ₹1.00 crore in Mar 2026, reflecting an increase of 61.00% on a QoQ basis.
  • The earnings per share (EPS) of NEPHRO CARE INDIA LIMITED stood at ₹2.04 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
61.71%
FII
0.73%
Other DII
0.86%
Retail and other
36.71%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20253.47%
Mar 20260.73%
Jun 20260.96%
Sep 20260.73%

NEPHRO CARE INDIA LIMITED Investment Returns

1 day
+3.03%
1 week
+1.07%
1 month
-4.76%
1 year
-37.54%
3 years
-55.47%
5 years
-55.47%

NEPHRO CARE INDIA LIMITED Share Price History

NEPHRO CARE INDIA LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
09 Nov 26
₹80.05 / ₹79.95
+3.03%
08 Nov 26
₹79.40 / ₹77.60
+1.77%
06 Nov 26
₹76.65 / ₹76.25
-0.52%
05 Nov 26
₹81.00 / ₹76.65
-0.90%
Show more

NEPHRO CARE INDIA LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026
Revenue₹88.73
Other Income₹1.55
Total Revenue₹90.28
Total Expenses₹85.64
Profit Before Tax₹4.64
Tax₹1.27
Profit After Tax₹3.37
EPS - Basic₹2.04
EPS - Diluted₹2.04

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026
Profit before tax₹4.64
Income before WC changes₹9.35
Change in Assets-₹6.16
Change in Liabilities₹0.78
Change in WC-₹5.37
Cash flow from Operations₹2.21
Cash flow from Investing-₹0.43
Cash flow from Financing₹0.05
Total Cash Flow₹1.83
Cash (Start of the year)₹4.66
Cash (End of the year)₹6.49

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026
Non-Current Assets₹41.93
Current Assets₹30.79
Total Assets₹72.72
Current Liabilities₹15.28
Net Current Asset₹15.51
Non-Current Liabilities₹0.54
Equity Capital₹56.90
Total Equity & Liabilities₹72.72

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹88.73₹46.03₹27.23₹17.09
Other Income₹1.55₹1.53₹0.37₹0.00
Total Revenue₹90.28₹47.56₹27.60₹17.09
Total Expenses₹85.64₹42.73₹21.38₹14.52
Profit Before Tax₹4.64₹4.83₹6.22₹2.58
Tax₹1.27₹1.19₹1.72₹0.20
Profit After Tax₹3.37₹3.64₹4.50₹2.37
EPS - Basic₹2.04₹2.20₹3.80₹2.37
EPS - Diluted₹2.04₹2.20₹3.80₹2.37

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹4.64₹4.83₹6.22₹2.58
Income before WC changes₹9.35₹5.98₹6.48₹3.37
Change in Assets-₹6.16-₹6.77-₹4.97-₹0.12
Change in Liabilities₹0.78₹9.09₹1.69₹0.92
Change in WC-₹5.37₹2.32-₹3.28₹0.80
Cash flow from Operations₹2.21₹7.24₹0.91₹4.12
Cash flow from Investing-₹0.48-₹39.56-₹7.54-₹2.33
Cash flow from Financing₹0.00₹35.96₹5.60-₹0.08
Total Cash Flow₹1.73₹3.63-₹1.03₹1.71
Cash (Start of the year)₹4.66₹1.29₹2.32₹0.61
Cash (End of the year)₹6.39₹4.66₹1.29₹2.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹41.99₹40.05₹10.06₹5.32
Current Assets₹30.68₹28.24₹10.91₹2.94
Total Assets₹72.67₹68.28₹20.97₹8.26
Current Liabilities₹15.27₹14.03₹5.86₹3.29
Net Current Asset₹15.41₹14.20₹5.04-₹0.35
Non-Current Liabilities₹0.54₹0.77₹0.08₹2.44
Equity Capital₹56.85₹53.48₹15.03₹2.53
Total Equity & Liabilities₹72.67₹68.28₹20.97₹8.26
* All values are in INR Crore
NEPHRO CARE INDIA LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
NEPHRO CARE INDIA LIMITED technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
44.37
Neutral
ATR (14)
3.92
Neutral
STOCH(9,6)
49.75
Neutral
STOCH RSI (14)
83.19
Bearish
ADX(9)
24.55
Bearish
UO(9)
40.79
Neutral
ROC(12)
-3.67
Bearish
WillR(14)
-54.55
Neutral
Period
Simple value
Exponential vaue
5D
77.56
78.46
10D
78.95
79.21
20D
81.68
81.23
50D
87.67
83.51
100D
80.25
81.97
Volume trend — traded volume by day
9 Nov0L
8 Nov0L
6 Nov0L
5 Nov0L
4 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

NEPHRO CARE INDIA LIMITED
Healthcare Services
Add Stock
Add Another

NEPHRO CARE INDIA LIMITED Returns Calculator

Top Gainers

CHEMPLASTS Share Price
₹237.83
+24.42 (+11.44%)
DATAPATTNS Share Price
₹4025.00
+321 (+8.67%)
QUESS Share Price
₹345.70
+27.15 (+8.52%)
SPARC Share Price
₹210.80
+13.77 (+6.99%)
GLAXO Share Price
₹2710.00
+170.4 (+6.71%)
See more

Top Losers

RRKABEL Share Price
₹1969.40
-146 (-6.9%)
FINCABLES Share Price
₹1232.40
-76.6 (-5.85%)
ALIVUS Share Price
₹1474.40
-84.3 (-5.41%)
TTML Share Price
₹39.33
-2.18 (-5.25%)
STLTECH Share Price
₹670.95
-35.3 (-5%)
See more

NEPHRO CARE INDIA LIMITED Share Price FAQs

Please be aware that NEPHRO CARE INDIA LIMITED stock prices are subject to continuous fluctuations due to various factors.